Table 1 Baseline Clinical Characteristics between SMI vs. non SMI in DM.

From: Chronic kidney disease is a key predictive factor for potential myocardial ischaemia and poor prognosis in asymptomatic patients with diabetes mellitus

Variable

SMI

non SMI

P value

n = 81

n = 380

Age (years)

69.0 ± 12.0

59.2 ± 14.7

< 0.001

Female

34 (42.0)

136 (35.8)

0.29

Body mass index (kg/m2)

24.0 ± 4.4

25.5 ± 5.5

0.0078

Duration since diagnosis of DM (years)

11.6 ± 9.1

7.1 ± 8.0

< 0.001

Insulin use

28 (34.6)

76 (20)

0.0044

HbA1c (%)

8.6 ± 2.3

8.7 ± 2.6

0.69

Retinopathy

31 (38.3)

68 (18.0)

< 0.001

Hypertension

55 (67.9)

197 (51.8)

0.0084

Dyslipidemia

48 (59.3)

197 (51.8)

0.22

Hyperuricemia

13 (16.0)

42 (11.1)

0.21

Smoking

51 (63.0)

223 (58.7)

0.48

Prior myocardial infarction

16 (19.8)

18 (4.7)

< 0.001

Statin use

25 (30.9)

107 (28.2)

0.62

Serum Creatinine (mg/dl)

0.91 ± 0.88

0.72 ± 0.39

0.2

eGFR (ml/min/1.73 m2)

70.5 ± 23.8

81.8 ± 30.0

< 0.001

Proteinuria

29 (35.8)

118 (31.1)

0.4

Urinary albumin (mg/gCr) (n = 344)

62 (23–195)

30 (14–71)

< 0.001

Log urinary albumin (n = 344)

1.85 ± 0.70

1.47 ± 0.59

< 0.001

BNP (pg/ml) (n = 313)

29 (13–73)

14 (7–30)

< 0.001

LVEF (%) (n = 346)

72 (63–75)

72 (68–76)

0.056

  1. Data are expressed as n (%), the mean ± standard deviation (SD) or median (interquartile range); eGFR, estimated glomerular filtration; BNP B-type natriuretic peptide; LVEF left ventricular ejection fraction.
Back to article page